FDA.reportPublic FDA data

benzgalantamine 5 MG Delayed Release Oral Tablet

RxCUI
2690632
RxNorm name
benzgalantamine 5 MG Delayed Release Oral Tablet
Display name
benzgalantamine 5 MG Delayed Release Oral Tablet
Full name
benzgalantamine 5 MG Delayed Release Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:16

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
af47bf67-1f07-4650-8064-24c38afc4656benzgalantamine 5 MG Delayed Release Oral Tablet [PSN] · benzgalantamine 5 MG Delayed Release Oral Tablet [SCD] · benzgalantamine 5 MG (equivalent to benzgalantamine gluconate 7.49 MG) Delayed Release Oral Tablet [SY]35These highlights do not include all the information needed to use ZUNVEYL safely and effectively. See full prescribing information for ZUNVEYL. ZUNVEYL (benzgalantamine) delayed-release tablets, for oral use Initial U.S. Approval: 200120260317